Healthcare Realty Trust 10-Q 4 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 31, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'HEALTHCARE REALTY TRUST INC	'
Entity Central Index Key	'0000899749	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	98,177,187

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Real estate properties:	'	'
Land	$183,991	$178,931
Buildings, improvements and lease intangibles	3,030,960	2,861,935
Personal property	9,535	9,267
Land held for development	17,054	17,054
Real estate properties, Total	3,241,540	3,067,187
Less accumulated depreciation	-693,517	-632,109
Total real estate properties, net	2,548,023	2,435,078
Cash and cash equivalents	1,684	8,671
Mortgage notes receivable	1,900	125,547
Assets held for sale and discontinued operations, net	11,479	6,852
Other assets, net	178,238	153,514
Total assets	2,741,324	2,729,662
Liabilities:	'	'
Notes and bonds payable	1,403,379	1,348,459
Accounts payable and accrued liabilities	60,017	73,741
Liabilities of discontinued operations	508	1,112
Other liabilities	57,913	61,064
Total liabilities	1,521,817	1,484,376
Commitments and contingencies	'	'
Equity:	'	'
Preferred stock, $.01 par value; 50,000 shares authorized; none issued and outstanding	0	0
Common stock, $.01 par value; 150,000 shares authorized; 98,119 and 95,924 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	981	959
Additional paid-in capital	2,374,345	2,325,228
Accumulated other comprehensive income	51	51
Cumulative net income attributable to common stockholders	822,176	808,362
Cumulative dividends	-1,978,046	-1,891,123
Total stockholders’ equity	1,219,507	1,243,477
Noncontrolling interest	0	1,809
Total equity	1,219,507	1,245,286
Total liabilities and equity	$2,741,324	$2,729,662

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Preferred stock, par value (dollars per share)	$0.01	$0.01
Preferred stock, authorized shares	50,000,000	50,000,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Common stock, par value (dollars per share)	$0.01	$0.01
Common stock, authorized shares	150,000,000	150,000,000
Common stock, issued shares	98,119,000	95,924,000
Common stock, outstanding shares	98,119,000	95,924,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
REVENUES	'	'	'	'
Rental income	$92,987	$78,161	$270,513	$230,094
Mortgage interest	44	3,926	3,634	10,290
Other operating	1,475	1,579	4,349	4,542
Revenues	94,506	83,666	278,496	244,926
EXPENSES	'	'	'	'
Property operating	34,678	32,244	102,077	92,742
General and administrative	5,190	5,582	16,834	17,961
Depreciation	25,660	21,716	74,408	63,970
Amortization	2,656	2,595	8,190	7,819
Bad debt, net of recoveries	3	109	123	116
Total Expenses	68,187	62,246	201,632	182,608
OTHER INCOME (EXPENSE)	'	'	'	'
Loss on extinguishments of debt	0	0	'	-29,638
Interest expense	-18,192	-17,043	-54,176	-55,738
Interest and other income, net	410	237	2,545	686
Total other income (expense)	-17,782	-16,806	-51,631	-84,690
INCOME (LOSS) FROM CONTINUING OPERATIONS	8,537	4,614	25,233	-22,372
DISCONTINUED OPERATIONS	'	'	'	'
Income (loss) from discontinued operations	121	1,241	-75	4,818
Impairments	-4,505	-6,259	-11,034	-9,889
Gain on sales of real estate properties	0	20,187	3	21,970
INCOME (LOSS) FROM DISCONTINUED OPERATIONS	-4,384	15,169	-11,106	16,899
NET INCOME (LOSS)	4,153	19,783	14,127	-5,473
Less: Net (income) loss attributable to noncontrolling interests	-162	-18	-313	34
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	$3,991	$19,765	$13,814	($5,439)
BASIC EARNINGS (LOSS) PER COMMON SHARE:	'	'	'	'
Income (loss) from continuing operations (in dollars per share)	$0.09	$0.05	$0.27	($0.25)
Discontinued operations (in dollars per share)	($0.05)	$0.16	($0.12)	$0.19
Net income (loss) attributable to common stockholders (in dollars per share)	$0.04	$0.21	$0.15	($0.06)
DILUTED EARNINGS (LOSS) PER COMMON SHARE:	'	'	'	'
Income (loss) from continuing operations (in dollars per share)	$0.09	$0.05	$0.26	($0.25)
Discontinued operations (in dollars per share)	($0.05)	$0.16	($0.12)	$0.19
Net income (loss) attributable to common stockholders (in dollars per share)	$0.04	$0.21	$0.14	($0.06)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC (in shares)	95,858,034	93,442,828	94,845,532	89,871,097
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - DILUTED (in shares)	97,329,044	94,835,994	96,310,418	89,871,097
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD (in dollars per share)	$0.30	$0.30	$0.90	$0.90

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
NET INCOME (LOSS)	$4,153	$19,783	$14,127	($5,473)
Less: Comprehensive (income) loss attributable to noncontrolling interests	-162	-18	-313	34
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	$3,991	$19,765	$13,814	($5,439)

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
OPERATING ACTIVITIES	'	'
Net income (loss)	$14,127	($5,473)
Adjustments to reconcile net income (loss) to cash provided by operating activities:	'	'
Depreciation and amortization	86,349	77,728
Stock-based compensation	3,400	4,131
Straight-line rent receivable	-7,907	-5,654
Straight-line rent liability	522	311
Gain on sales of real estate properties	-3	-21,970
Loss on extinguishment of debt	0	29,907
Impairments	11,034	9,889
Provision for bad debt, net of recoveries	126	119
Changes in operating assets and liabilities:	'	'
Other assets	-16,231	-5,988
Accounts payable and accrued liabilities	-10,644	-10,273
Other liabilities	-3,123	-788
Net cash provided by operating activities	77,650	71,939
INVESTING ACTIVITIES	'	'
Acquisitions of real estate	-37,694	-104,451
Additional long-lived assets	-54,899	-52,199
Funding of mortgages	-1,244	-57,780
Proceeds from acquisition of real estate upon mortgage note receivable default	204	0
Proceeds from sales of real estate	6,134	75,855
Proceeds from mortgages and notes receivable repayments	5,618	643
Net cash used in investing activities	-81,881	-137,932
FINANCING ACTIVITIES	'	'
Net borrowings (repayments) on unsecured credit facility	-154,000	75,000
Borrowings on term loan	200,000	0
Borrowings on notes and bonds payable	0	247,948
Repayments on notes and bonds payable	-4,415	-18,655
Redemption of notes and bonds payable	0	-371,839
Dividends paid	-86,923	-82,815
Net proceeds from issuance of common stock	52,712	220,045
Common stock redemptions	-382	-247
Capital contributions received from noncontrolling interest holders	0	1,749
Distributions to noncontrolling interest holders	-380	-32
Purchase of noncontrolling interest	-8,189	0
Debt issuance and assumption costs	-1,179	-4,777
Net cash provided by (used in) financing activities	-2,756	66,377
Increase (decrease) in cash and cash equivalents	-6,987	384
Cash and cash equivalents, beginning of period	8,671	6,776
Cash and cash equivalents, end of period	1,684	7,160
Supplemental Cash Flow Information:	'	'
Interest paid	59,227	62,326
Company-financed real estate property sales	1,900	4,241
Invoices accrued for construction, tenant improvement and other capitalized costs	4,662	6,291
Mortgage notes payable assumed upon acquisition (adjusted to fair value)	12,618	12,678
Capitalized interest	0	183
Elimination of construction mortgage note receivable upon acquisition real estate property	$0	$97,203

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Summary of Significant Accounting Policies
	Business Overview
	Healthcare Realty Trust Incorporated (the “Company”) is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. The Company had investments of approximately $3.2 billion in 201 real estate properties and mortgages as of September 30, 2014. The Company’s 200 owned real estate properties are located in 30 states and total approximately 14.3 million square feet. The Company provided property management services to approximately 9.7 million square feet nationwide.
	Basis of Presentation
	The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein, management believes there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K for the year ended December 31, 2013. All material intercompany transactions and balances have been eliminated in consolidation.
	This interim financial information should be read in conjunction with the financial statements and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in this report and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2014 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.
	Use of Estimates in the Condensed Consolidated Financial Statements
	Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.
	Interest and Other Income, Net
	Included in "Interest and other income, net" for the nine months ended September 30, 2014 is $1.9 million recognized for a cash reimbursement received by the Company for certain operating expenses paid by the Company for years 2006 through 2013 and a gain recognized from insurance proceeds of approximately $0.3 million.
	New Accounting Pronouncements
	Accounting Standards Update No. 2014-09
	In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2014-09, "Revenue from Contracts with Customers", a comprehensive new revenue recognition standard that supersedes most all existing revenue recognition guidance, including sales of real estate. This standard's core principle is that a company will recognize revenue when it transfers goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods and services. However, leasing contracts, representing the major source of the Company's revenues, are not within the scope of the new standard and will continue to be accounted for under existing standards.
	This new standard is effective for the Company for annual and interim periods beginning on January 1, 2017 with early adoption prohibited. The Company has not yet determined the effects on the Consolidated Financial Statements and related notes resulting from the adoption of this new standard.
	Accounting Standards Update No. 2014-08
	In April 2014, the FASB issued Accounting Standards Update No. 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” This standard changes the requirements for reporting discontinued operations by raising the threshold for a disposal to qualify as a discontinued operation and requires new disclosures of both discontinued operations and certain other disposals that do not meet the definition of a discontinued operation. The standard limits discontinued operations reporting to disposals of components of an entity that represent strategic shifts that have (or will have) a major effect on an entity’s operations and financial results.
	This standard is effective for the Company on a prospective basis for annual periods beginning on January 1, 2015 and interim periods within that year. Early adoption is permitted but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. The Company is still evaluating the impact of this new standard but does not expect it to have a material effect on the Consolidated Financial Statements, when adopted.
	Reclassifications
	Certain amounts in the Company’s Condensed Consolidated Financial Statements for prior periods have been reclassified to conform to the current period presentation. Assets held for sale, and related liabilities, have been reclassified in the Company’s Condensed Consolidated Balance Sheets, and the operating results of those net assets, including assets sold, have been reclassified from continuing to discontinued operations for all periods presented.

Real_Estate_Investments

Real Estate Investments	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Real Estate Investments	'
	Real Estate Investments
	2014 Acquisitions
	Third Quarter
	In July 2014, the Company purchased a 60,476 square foot medical office building located in Minnesota for a purchase price of $19.8 million including cash consideration of $8.4 million and the assumption of debt of $11.4 million (excluding a $1.2 million fair value adjustment premium recorded upon acquisition). The mortgage notes payable assumed by the Company bear a weighted average contractual interest rate of 6.67% with maturities from 2017 to 2040. See Note 3 for more information on the debt assumed. The property was constructed in 2010 and is 100% leased with expirations through 2025. The building is connected to Unity Hospital, a 220-bed hospital operated by Allina Health.
	In September 2014, the Company purchased a 47,962 square foot medical office building located in Florida for a purchase price and cash consideration of $7.9 million. The property is 89% leased with expirations through 2019. The building is adjacent to Tampa General Hospital, a 1,018-bed hospital.
	Second Quarter
	In May 2014, the Company purchased a 200,000 square foot medical office building in Oklahoma for a purchase price of approximately $85.4 million that is 100% leased to Mercy Health, based in Missouri, through 2028 under a single-tenant net lease. The Company funded the development of the facility through a construction mortgage loan of approximately $81.2 million that upon purchase was eliminated in the Company's Condensed Consolidated Financial Statements. At the closing of the purchase, the outstanding loan balance was credited to the purchase price and the Company paid an additional $4.2 million in cash consideration. Subsequent to the purchase, the Company funded an additional $4.0 million and anticipates funding approximately $1.8 million to complete the $91.2 million development during the fourth quarter of 2014.
	In June 2014, the Company purchased a 56.9% equity interest in a limited liability company that owns a medical office building and related land in Texas. The Company paid $8.8 million in cash consideration including closing costs of $0.1 million. Based on the nature of the transaction, the Company has accounted for the acquisition as an asset acquisition and has recorded the amounts in real estate assets on the Company's Condensed Consolidated Balance Sheet. The building is adjacent to Seton Medical Center, a 534-bed hospital.
	Also in June 2014, the Company purchased a 35,292 square foot medical office building located in North Carolina for a purchase price and cash consideration of $6.5 million. The property is 100% leased with expirations through 2024. The building is adjacent to Wesley Long Hospital, a 175-bed hospital.
	First Quarter
	In March 2014, the Company acquired ownership of a multi-tenanted office building in Iowa in satisfaction of a $40.0 million mortgage note receivable that matured on January 10, 2014. The cash flows from the operations of the property were sufficient to pay the Company interest from the maturity date through the date of the transfer of ownership to the Company at the 7.7% fixed interest rate plus an additional 3% of interest for the default interest rate. The Company has accounted for this transaction as a business combination and recorded the acquisition of the property at its estimated fair value based primarily on Level 3 inputs. The Company did not recognize any of the $1.5 million exit fee receivable that was due upon maturity of the mortgage note receivable. The following table details the purchase price accounting for this transaction.
		Estimated Fair Value				Estimated Useful Life
		(In millions)				(In years)
	Building	$	38.1			11.5-33.0
	Intangibles:
	At-market lease intangibles	2.1				5.8
	Below-market ground lease intangibles	(0.1		)		91.3
	Below-market lease intangibles	(0.4		)		3.8-6.5
	Total intangibles	1.6
	Foreclosed mortgage note receivable	(40.0		)
	Other assets acquired	1.8
	Accounts payable, accrued liabilities and other liabilities assumed	(1.7		)
	Cash acquired	0.2
	Total cash paid	$	—
	The following table details the Company's acquisitions for the nine months ended September 30, 2014:
	(Dollars in millions)	Date		Purchase Price				Elimination of Mortgage Note Receivable				Mortgage				Cash		Real		Other			Square
		Acquired										Notes Payable Assumed				Consideration		Estate					Footage
	Real estate acquisitions
	Iowa	3/28/14		$	—			$	(40.0	)		$	—			$	—	$	40.2	$	(0.2	)	152,655
	Oklahoma	5/22/14		85.4				(81.2		)		—				4.2		85.4		—			200,000
	Texas	6/4/14		8.7				—				—				8.8		8.8		—			48,048
	North Carolina	6/6/14		6.5				—				—				6.5		6.5		—			35,292
	Minnesota (1)	7/28/14		19.8				—				(11.4		)		8.4		21		(1.2		)	60,476
	Florida	9/16/14		7.9				—				—				7.9		7.9		—			47,962
				$	128.3			$	(121.2	)		$	(11.4	)		$	35.8	$	169.8	$	(1.4	)	544,433
	______
	(1) The mortgage note payable assumed in the acquisition does not reflect the fair value adjustment of $1.2 million recorded by the Company upon acquisition (included in Other).
	Subsequent Acquisition
	In October 2014, the Company acquired a 68,860 square foot medical office building in Oklahoma for a purchase price of $17.4 million, including cash consideration of $10.6 million and the assumption of debt of $6.8 million. The mortgage note payable, assumed by the Company, bears a contractual interest rate of 6.1% and matures on August 1, 2020. The property is 96.7% leased with expirations through 2027. The building is located on the Norman Regional Healthplex campus, a 152-bed specialty hospital.
	2014 Dispositions
	Third Quarter
	In September 2014, the Company disposed of an on-campus 31,026 square foot medical office building located in Nevada in which the Company had a $4.9 million net investment. The sales price was approximately $2.3 million, comprised of net cash proceeds of approximately $0.2 million, a seller-financed mortgage note of $1.9 million, and closing costs of $0.2 million. The Company recognized a $2.8 million impairment on the disposal of this property that was not previously classified as held for sale.
	Second Quarter
	In April 2014, the Company disposed of an off-campus, medical office building located in Florida that was previously classified as held for sale and in which the Company had a $1.7 million net investment, including a $0.9 million impairment charge recorded in the first quarter of 2014 as a result of the pending sale and previously recorded impairment charges of $2.4 million. The sales price was $1.8 million, comprised of $1.7 million in net cash proceeds and closing costs of $0.1 million.
	Also in April 2014, the Company disposed of an off-campus, medical office building located in Texas that was classified as held for sale and in which the Company had a $4.1 million net investment, including a $2.6 million impairment charge recorded in the first quarter of 2014 as a result of the pending sale. The sales price was $4.4 million, comprised of $4.2 million in net cash proceeds and closing costs of $0.2 million.
	A summary of the Company's 2014 dispositions are as follows:
	(Dollars in millions)	Date		Sales Price				Closing Adjustments				Company-financed Mortgage				Net		Net Real		Other			Gain/			Square
		Disposed										Notes				Proceeds		Estate		(including			(Impairment)			Footage
																		Investment		receivables)
	Real estate dispositions
	Florida (1)	4/11/14		$	1.8			$	(0.1	)		$	—			$	1.7	$	1.7	$	—		$	—		52,608
	Texas (1)	4/23/14		4.4				(0.2		)		—				4.2		4.1		0.1			—			58,365
	Nevada	9/12/14		2.3				(0.2		)		(1.9		)		0.2		4.9		—			(2.8		)	31,026
	Total dispositions			8.5				(0.5		)		(1.9		)		6.1		10.7		0.1			(2.8		)	141,999
	Mortgage note repayments			—				—				4.9				4.9		—		—			—			—
				$	8.5			$	(0.5	)		$	3			$	11	$	10.7	$	0.1		$	(2.8	)	141,999
	______
	(1) Previously included in assets held for sale.
	Potential Disposition
	In September 2014, the Company received notice from a tenant of its intent to purchase a medical office building in Pennsylvania pursuant to a purchase option contained in its lease with the Company. The Company's net investment in the building is $7.7 million at September 30, 2014, including straight-line rent receivables. The purchase price for the property will be the greater of a fair market value or approximately $15.0 million. The appraisal process is on-going and the sale will result in a potential gain of at least $7.3 million. The Company preliminarily expects the sale to occur during the first quarter of 2015. The property was reclassified as held for sale as of September 30, 2014.
	Company-Financed Mortgage Notes
	During the third quarter of 2014, two mortgage notes receivable were repaid generating an aggregate of $4.9 million in net proceeds.
	In September 2014, the Company originated a $1.9 million seller-financed mortgage note receivable with the purchaser of a medical office building located in Nevada that was sold by the Company as discussed in "2014 Dispositions" above.
Noncontrolling Interest Purchase
In April 2014, the Company purchased the outstanding 40% noncontrolling equity interest in a consolidated partnership that owns a medical office building and parking garage in Texas, which were developed by the partnership, for an aggregate purchase price and cash consideration of $8.2 million. The book value of the noncontrolling interest prior to the equity purchase was $1.6 million. The Company held a term loan that was secured by the property and was payable from the partnership. Upon acquisition of the noncontrolling interest, the term loan, which was previously eliminated in the Company's Condensed Consolidated Financial Statements, was extinguished.
Discontinued Operations and Assets Held for Sale
During the third quarter of 2014, the Company reclassified one property to held for sale. See "Potential Dispositions" above for more information.
Also, during the third quarter of 2014, the Company received an offer and is in negotiations regarding the purchase one of its buildings that was classified as held for sale. The offer is less than the Company's net investment resulting in an impairment charge of $1.8 million which was recorded in the third quarter of 2014. The fair value amount used to calculate the impairment was based on the expected sales price less costs to sell, which is a Level 3 input.
At September 30, 2014 and December 31, 2013, the Company had four and three properties classified as held for sale, respectively.
The tables below reflect the assets and liabilities of the properties classified as held for sale and discontinued operations as of September 30, 2014 and December 31, 2013 and the results of operations of the properties included in discontinued operations on the Company's Consolidated Statements of Operations for three and nine months ended September 30, 2014 and 2013.
(Dollars in thousands)	September 30,				December 31,
	2014				2013
Balance Sheet data:
Land	$	1,674			$	1,578
Buildings, improvements and lease intangibles	22,232				15,400
Personal property	14				—
	23,920				16,978
Accumulated depreciation	(12,901		)		(10,211		)
Assets held for sale, net	11,019				6,767
Other assets, net (including receivables)	460				85
Assets of discontinued operations, net	460				85
Assets held for sale and discontinued operations, net	$	11,479			$	6,852
Accounts payable and accrued liabilities	$	482			$	1,091
Other liabilities	26				21
Liabilities of discontinued operations	$	508			$	1,112
	Three Months Ended September 30,								Nine Months Ended September 30,
(Dollars in thousands)	2014				2013				2014				2013
Statements of Operations data:
Revenues
Rental income	$	465			$	2,608			$	1,689			$	9,771
Other Operating Income	—				—				—				1
	465				2,608				1,689				9,772
Expenses
Property operating	251				724				1,223				2,221
General and administrative	1				1				3				4
Depreciation	104				649				544				2,390
Amortization	—				12				—				55
Bad debt, net of recoveries	(4		)		3				3				3
	352				1,389				1,773				4,673
Other Income (Expense)
Loss on extinguishment of debt	—				—				—				(270		)
Interest expense	—				—				—				(40		)
Interest and other income, net	8				22				9				29
	8				22				9				(281		)
Discontinued Operations
Income (loss) from discontinued operations	121				1,241				(75		)		4,818
Impairments	(4,505		)		(6,259		)		(11,034		)		(9,889		)
Gain on sales of real estate properties	—				20,187				3				21,970
Income (Loss) from Discontinued Operations	$	(4,384	)		$	15,169			$	(11,106	)		$	16,899

Notes_and_Bonds_Payable

Notes and Bonds Payable	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Notes and Bonds Payable	'
	Notes and Bonds Payable
	Third Quarter
	In July 2014, upon the acquisition of a real estate property, the Company assumed a series 2010B Bond due 2017 totaling $0.5 million, a Series 2010A Bond due 2022 totaling $1.2 million, a Series 2010A Bond due 2030 totaling $2.8 million and a Series 2010A Bond due 2040 totaling $7.0 million. The aggregate outstanding balance of these bonds is approximately $11.4 million excluding a fair value adjustment premium recorded upon acquisition of approximately $1.2 million. The mortgage notes payable have a weighted average contractual interest rate of 6.67% (effective rate of 4.79%). The Series 2010A Bonds can be repaid without penalty on or after May 1, 2020. See Note 2 of the Condensed Consolidated Financial Statements for more information regarding this transaction.
	First Quarter
	In February 2014, the Company entered into a $200.0 million unsecured term loan facility ("Term Loan due 2019") with a syndicate of nine lenders that matures on February 26, 2019. The Term Loan due 2019 bears interest at a rate equal to (x) LIBOR plus (y) a margin ranging from 1.00% to 1.95% (currently 1.45%) based upon the Company's unsecured debt ratings. Payments under the Term Loan due 2019 are interest only, with the full amount of the principal due at maturity. The Term Loan due 2019 may be prepaid at any time, without penalty. The proceeds from the Term Loan due 2019 were used by the Company to repay borrowings on its unsecured revolving credit facility due 2017 ("Unsecured Credit Facility"). The Term Loan due 2019 has various financial covenant provisions that are required to be met on a quarterly and annual basis that are equivalent to those of the Unsecured Credit Facility. The Company was in compliance with the financial covenant provisions at September 30, 2014.
	Subsequent Activity
	In October 2014, the Company repaid three mortgage notes payable totaling $6.3 million bearing a weighted average contractual interest rate of 6.08% (effective rate of 4.06%) that encumbered two medical office buildings in Virginia.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Legal Proceedings
	The Company is, from time to time, involved in litigation arising in the ordinary course of business or which is expected to be covered by insurance. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

Equity

Equity	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Equity	'
	Equity
	The following table provides a reconciliation of total equity for the nine months ended September 30, 2014:
	(Dollars in thousands, except per share data)	Common			Additional			Accumulated			Cumulative		Cumulative			Total			Non-controlling Interests			Total
		Stock			Paid-In			Other			Net		Dividends			Stockholders’						Equity
					Capital			Comprehensive			Income Attributable to Common Stockholders					Equity
								Income
	Balance at December 31, 2013	$	959		$	2,325,228		$	51		$	808,362	$	(1,891,123	)	$	1,243,477		$	1,809		$	1,245,286
	Issuance of common stock	21			52,677			—			—		—			52,698			—			52,698
	Common stock redemptions	—			(382		)	—			—		—			(382		)	—			(382		)
	Stock-based compensation	1			3,399			—			—		—			3,400			—			3,400
	Net income	—			—			—			13,814		—			13,814			313			14,127
	Dividends to common stockholders ($0.90 per share)	—			—			—			—		(86,923		)	(86,923		)	—			(86,923		)
	Distributions to non-controlling interests	—			—			—			—		—			—			(510		)	(510		)
	Purchase of noncontrolling interest in consolidated partnership	—			(6,577		)	—			—		—			(6,577		)	(1,612		)	(8,189		)
	Balance at September 30, 2014	$	981		$	2,374,345		$	51		$	822,176	$	(1,978,046	)	$	1,219,507		$	—		$	1,219,507
	The following schedule discloses the effects of changes in the Company's ownership interest in its less-than-wholly-owned subsidiary on the Company's stockholders' equity (in thousands):
		Nine Months Ended September 30, 2014
	Net income attributable to common stockholders	$	13,814
	Transfers to noncontrolling interest:
	Net decrease in the Company's additional paid-in capital for purchase of subsidiary partnership interest	(6,577		)
	Net transfers to the noncontrolling interest	(6,577		)
	Change to the Company's total stockholders' equity from net income attributable to common stockholders and transfers to noncontrolling interest	$	7,237
	Common Stock
	The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September 30, 2014 and the year ended December 31, 2013:
		September 30, 2014			December 31, 2013
	Balance, beginning of period	95,924,339			87,514,336
	Issuance of common stock	2,149,976			8,293,369
	Nonvested share-based awards, net	44,231			116,634
	Balance, end of period	98,118,546			95,924,339
	At-The-Market Equity Offering Program
	During the nine months ended September 30, 2014, the Company sold 2,099,380 shares of common stock under its at-the-market equity offering program, generating $51.8 million in net proceeds at prices ranging from $24.35 to $25.84 per share (weighted average of $25.05 per share). Of this amount, the Company sold 999,080 shares of common stock during the third quarter of 2014 generating $24.5 million in net proceeds at prices ranging from $24.35 to $25.50 per share (weighted average of $24.93 per share). In October 2014, the Company sold 58,504 shares of common stock, generating $1.5 million in net proceeds at prices ranging from $25.00 to $25.35 per share (weighted average of $25.32 per share).
	The Company's existing sales agreements with four investment banks allow sales under this program of up to 9,000,000 shares of common stock, with 3,233,516 authorized shares remaining available to be sold under the these agreements as of November 4, 2014.
	Common Stock Dividends
	During the first nine months of 2014, the Company declared and paid common stock dividends totaling $0.90 per share.
	On November 4, 2014, the Company declared a quarterly common stock dividend in the amount of $0.30 per share payable on November 28, 2014 to stockholders of record on November 14, 2014.
	Earnings (Loss) Per Common Share
	The following table sets forth the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2014 and 2013.
		Three Months Ended September 30,								Nine Months Ended September 30,
	(Dollars in thousands, except per share data)	2014				2013				2014			2013
	Weighted average Common Shares outstanding
	Weighted average Common Shares outstanding	97,651,673				95,220,031				96,677,774			91,665,703
	Nonvested shares	(1,793,639		)		(1,777,203		)		(1,832,242		)	(1,794,606		)
	Weighted average Common Shares outstanding—Basic	95,858,034				93,442,828				94,845,532			89,871,097
	Weighted average Common Shares—Basic	95,858,034				93,442,828				94,845,532			89,871,097
	Dilutive effect of restricted stock	1,369,047				1,278,902				1,346,032			—
	Dilutive effect of employee stock purchase plan	101,963				114,264				118,854			—
	Weighted average Common Shares outstanding—Diluted	97,329,044				94,835,994				96,310,418			89,871,097
	Net Income (Loss)
	Income (loss) from continuing operations	$	8,537			$	4,614			$	25,233		$	(22,372	)
	Noncontrolling interests’ share in net (income) loss	(162		)		(18		)		(313		)	34
	Income (loss) from continuing operations attributable to common stockholders	8,375				4,596				24,920			(22,338		)
	Discontinued operations	(4,384		)		15,169				(11,106		)	16,899
	Net income (loss) attributable to common stockholders	$	3,991			$	19,765			$	13,814		$	(5,439	)
	Basic Earnings (Loss) Per Common Share
	Income (loss) from continuing operations	$	0.09			$	0.05			$	0.27		$	(0.25	)
	Discontinued operations	(0.05		)		0.16				(0.12		)	0.19
	Net income (loss) attributable to common stockholders	$	0.04			$	0.21			$	0.15		$	(0.06	)
	Diluted Earnings (Loss) Per Common Share
	Income (loss) from continuing operations	$	0.09			$	0.05			$	0.26		$	(0.25	)
	Discontinued operations	(0.05		)		0.16				(0.12		)	0.19
	Net income (loss) attributable to common stockholders	$	0.04			$	0.21			$	0.14		$	(0.06	)
	The effect of 1,294,953 nonvested shares and options to purchase 164,418 shares of the Company's common stock for the nine months ended September 30, 2013 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period.
	Incentive Plans
The Company has various stock-based incentive plans for its employees and directors. Awards under these plans include nonvested common stock issued to employees and the Company’s directors. During the nine months ended September 30, 2014 and 2013, the Company issued 128,199 and 87,043 shares of nonvested common stock, respectively, to participants under these incentive plans and withheld 16,170 and 9,433 shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested.
A summary of the activity under the stock-based incentive plans for the three and nine months ended September 30, 2014 and 2013 is included in the table below.
	Three Months Ended September 30,						Nine Months Ended September 30,
	2014			2013			2014			2013
Stock-based awards, beginning of period	1,837,855			1,778,083			1,788,168			1,770,061
Granted	—			—			128,199			87,043
Vested	(4,911	)		(890	)		(83,423	)		(79,911	)
Forfeited	(67,798	)		—			(67,798	)		—
Stock-based awards, end of period	1,765,146			1,777,193			1,765,146			1,777,193
The Company recorded approximately $0.2 million in general and administrative expenses during the first quarter of 2014 relating to the annual grant of options to its employees under the Employee Stock Purchase Plan based on the Company's estimate of option exercises.
A summary of the activity under the Employee Stock Purchase Plan for the three and nine months ended September 30, 2014 and 2013 is included in the table below.
	Three Months Ended September 30,						Nine Months Ended September 30,
	2014			2013			2014			2013
Outstanding and exercisable, beginning of period	440,471			433,801			391,108			433,452
Granted	—			—			275,655			246,717
Exercised	(11,668	)		(7,478	)		(40,988	)		(60,483	)
Forfeited	(5,219	)		(14,007	)		(44,316	)		(36,819	)
Expired	—			—			(157,875	)		(170,551	)
Outstanding and exercisable, end of period	423,584			412,316			423,584			412,316

Defined_Benefit_Pension_Plan

Defined Benefit Pension Plan	9 Months Ended
	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
Defined Benefit Pension Plan	'
	Defined Benefit Pension Plan
	The Company’s Executive Retirement Plan provides benefits upon retirement for three of the Company’s founding officers. The plan is unfunded and benefits will be paid from cash flows of the Company. The maximum annual benefits payable to each individual under the Executive Retirement Plan is $0.9 million, subject to cost-of-living adjustments. As of September 30, 2014, only the Company’s Chief Executive Officer was eligible to retire under the Executive Retirement Plan.
	Net periodic benefit cost recorded related to the Company’s pension plan for the three and nine months ended September 30, 2014 and 2013 is detailed in the following table.
		Three Months Ended September 30,						Nine Months Ended September 30,
	(Dollars in thousands)	2014			2013			2014			2013
	Service cost	$	22		$	22		$	66		$	64
	Interest cost	172			149			515			448
	Amortization of net gain/loss	117			344			352			1,035
	Amortization of prior service cost	(297		)	(297		)	(892		)	(892		)
	Total recognized in net periodic benefit cost	$	14		$	218		$	41		$	655

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The carrying amounts of cash and cash equivalents, receivables and payables are reasonable estimates of their fair value as of September 30, 2014 and December 31, 2013 due to their short-term nature. The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. The fair value of mortgage notes receivable is estimated based either on cash flow analyses at an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company recently. The table below details the fair value and carrying values for notes and bonds payable and mortgage notes receivable at September 30, 2014 and December 31, 2013.
		September 30, 2014				December 31, 2013
	(Dollars in millions)	Carrying Value		Fair Value		Carrying Value		Fair Value
	Notes and bonds payable (1)	$	1,403.40	$	1,426.50	$	1,348.50	$	1,380.60
	Mortgage notes receivable (2)	$	1.9	$	1.9	$	125.5	$	124.5
	______
	(1) Level 3 - Fair value derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	(2) Level 2 - Fair value based on quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Business Overview	'
	Business Overview
	Healthcare Realty Trust Incorporated (the “Company”) is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. The Company had investments of approximately $3.2 billion in 201 real estate properties and mortgages as of September 30, 2014. The Company’s 200 owned real estate properties are located in 30 states and total approximately 14.3 million square feet. The Company provided property management services to approximately 9.7 million square feet nationwide.
Basis of Presentation	'
	Basis of Presentation
	The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein, management believes there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K for the year ended December 31, 2013. All material intercompany transactions and balances have been eliminated in consolidation.
	This interim financial information should be read in conjunction with the financial statements and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in this report and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2014 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.
Use of Estimates in the Condensed Consolidated Financial Statements	'
	Use of Estimates in the Condensed Consolidated Financial Statements
	Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.
New Accounting Pronouncements	'
	New Accounting Pronouncements
	Accounting Standards Update No. 2014-09
	In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2014-09, "Revenue from Contracts with Customers", a comprehensive new revenue recognition standard that supersedes most all existing revenue recognition guidance, including sales of real estate. This standard's core principle is that a company will recognize revenue when it transfers goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods and services. However, leasing contracts, representing the major source of the Company's revenues, are not within the scope of the new standard and will continue to be accounted for under existing standards.
	This new standard is effective for the Company for annual and interim periods beginning on January 1, 2017 with early adoption prohibited. The Company has not yet determined the effects on the Consolidated Financial Statements and related notes resulting from the adoption of this new standard.
	Accounting Standards Update No. 2014-08
	In April 2014, the FASB issued Accounting Standards Update No. 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” This standard changes the requirements for reporting discontinued operations by raising the threshold for a disposal to qualify as a discontinued operation and requires new disclosures of both discontinued operations and certain other disposals that do not meet the definition of a discontinued operation. The standard limits discontinued operations reporting to disposals of components of an entity that represent strategic shifts that have (or will have) a major effect on an entity’s operations and financial results.
	This standard is effective for the Company on a prospective basis for annual periods beginning on January 1, 2015 and interim periods within that year. Early adoption is permitted but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. The Company is still evaluating the impact of this new standard but does not expect it to have a material effect on the Consolidated Financial Statements, when adopted.
Reclassifications	'
	Reclassifications
	Certain amounts in the Company’s Condensed Consolidated Financial Statements for prior periods have been reclassified to conform to the current period presentation. Assets held for sale, and related liabilities, have been reclassified in the Company’s Condensed Consolidated Balance Sheets, and the operating results of those net assets, including assets sold, have been reclassified from continuing to discontinued operations for all periods presented.

Real_Estate_Investments_Tables

Real Estate Investments (Tables)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Schedule Of Real Estate Acquisitions by Geographic Location	'
	The following table details the purchase price accounting for this transaction.
		Estimated Fair Value				Estimated Useful Life
		(In millions)				(In years)
	Building	$	38.1			11.5-33.0
	Intangibles:
	At-market lease intangibles	2.1				5.8
	Below-market ground lease intangibles	(0.1		)		91.3
	Below-market lease intangibles	(0.4		)		3.8-6.5
	Total intangibles	1.6
	Foreclosed mortgage note receivable	(40.0		)
	Other assets acquired	1.8
	Accounts payable, accrued liabilities and other liabilities assumed	(1.7		)
	Cash acquired	0.2
	Total cash paid	$	—
Schedule of Business Acquisitions	'
	The following table details the Company's acquisitions for the nine months ended September 30, 2014:
	(Dollars in millions)	Date		Purchase Price				Elimination of Mortgage Note Receivable				Mortgage				Cash		Real		Other			Square
		Acquired										Notes Payable Assumed				Consideration		Estate					Footage
	Real estate acquisitions
	Iowa	3/28/14		$	—			$	(40.0	)		$	—			$	—	$	40.2	$	(0.2	)	152,655
	Oklahoma	5/22/14		85.4				(81.2		)		—				4.2		85.4		—			200,000
	Texas	6/4/14		8.7				—				—				8.8		8.8		—			48,048
	North Carolina	6/6/14		6.5				—				—				6.5		6.5		—			35,292
	Minnesota (1)	7/28/14		19.8				—				(11.4		)		8.4		21		(1.2		)	60,476
	Florida	9/16/14		7.9				—				—				7.9		7.9		—			47,962
				$	128.3			$	(121.2	)		$	(11.4	)		$	35.8	$	169.8	$	(1.4	)	544,433
	______
	(1) The mortgage note payable assumed in the acquisition does not reflect the fair value adjustment of $1.2 million recorded by the Company upon acquisition (included in Other).
Schedule of Dispositions	'
	A summary of the Company's 2014 dispositions are as follows:
	(Dollars in millions)	Date		Sales Price				Closing Adjustments				Company-financed Mortgage				Net		Net Real		Other			Gain/			Square
		Disposed										Notes				Proceeds		Estate		(including			(Impairment)			Footage
																		Investment		receivables)
	Real estate dispositions
	Florida (1)	4/11/14		$	1.8			$	(0.1	)		$	—			$	1.7	$	1.7	$	—		$	—		52,608
	Texas (1)	4/23/14		4.4				(0.2		)		—				4.2		4.1		0.1			—			58,365
	Nevada	9/12/14		2.3				(0.2		)		(1.9		)		0.2		4.9		—			(2.8		)	31,026
	Total dispositions			8.5				(0.5		)		(1.9		)		6.1		10.7		0.1			(2.8		)	141,999
	Mortgage note repayments			—				—				4.9				4.9		—		—			—			—
				$	8.5			$	(0.5	)		$	3			$	11	$	10.7	$	0.1		$	(2.8	)	141,999
	______
	(1) Previously included in assets held for sale.
Discontinued Operations and Assets Held for Sale	'
	The tables below reflect the assets and liabilities of the properties classified as held for sale and discontinued operations as of September 30, 2014 and December 31, 2013 and the results of operations of the properties included in discontinued operations on the Company's Consolidated Statements of Operations for three and nine months ended September 30, 2014 and 2013.
	(Dollars in thousands)	September 30,				December 31,
		2014				2013
	Balance Sheet data:
	Land	$	1,674			$	1,578
	Buildings, improvements and lease intangibles	22,232				15,400
	Personal property	14				—
		23,920				16,978
	Accumulated depreciation	(12,901		)		(10,211		)
	Assets held for sale, net	11,019				6,767
	Other assets, net (including receivables)	460				85
	Assets of discontinued operations, net	460				85
	Assets held for sale and discontinued operations, net	$	11,479			$	6,852
	Accounts payable and accrued liabilities	$	482			$	1,091
	Other liabilities	26				21
	Liabilities of discontinued operations	$	508			$	1,112
		Three Months Ended September 30,								Nine Months Ended September 30,
	(Dollars in thousands)	2014				2013				2014				2013
	Statements of Operations data:
	Revenues
	Rental income	$	465			$	2,608			$	1,689			$	9,771
	Other Operating Income	—				—				—				1
		465				2,608				1,689				9,772
	Expenses
	Property operating	251				724				1,223				2,221
	General and administrative	1				1				3				4
	Depreciation	104				649				544				2,390
	Amortization	—				12				—				55
	Bad debt, net of recoveries	(4		)		3				3				3
		352				1,389				1,773				4,673
	Other Income (Expense)
	Loss on extinguishment of debt	—				—				—				(270		)
	Interest expense	—				—				—				(40		)
	Interest and other income, net	8				22				9				29
		8				22				9				(281		)
	Discontinued Operations
	Income (loss) from discontinued operations	121				1,241				(75		)		4,818
	Impairments	(4,505		)		(6,259		)		(11,034		)		(9,889		)
	Gain on sales of real estate properties	—				20,187				3				21,970
	Income (Loss) from Discontinued Operations	$	(4,384	)		$	15,169			$	(11,106	)		$	16,899

Equity_Tables

Equity (Tables)	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Reconciliation of total equity	'
	The following table provides a reconciliation of total equity for the nine months ended September 30, 2014:
	(Dollars in thousands, except per share data)	Common			Additional			Accumulated			Cumulative		Cumulative			Total			Non-controlling Interests			Total
		Stock			Paid-In			Other			Net		Dividends			Stockholders’						Equity
					Capital			Comprehensive			Income Attributable to Common Stockholders					Equity
								Income
	Balance at December 31, 2013	$	959		$	2,325,228		$	51		$	808,362	$	(1,891,123	)	$	1,243,477		$	1,809		$	1,245,286
	Issuance of common stock	21			52,677			—			—		—			52,698			—			52,698
	Common stock redemptions	—			(382		)	—			—		—			(382		)	—			(382		)
	Stock-based compensation	1			3,399			—			—		—			3,400			—			3,400
	Net income	—			—			—			13,814		—			13,814			313			14,127
	Dividends to common stockholders ($0.90 per share)	—			—			—			—		(86,923		)	(86,923		)	—			(86,923		)
	Distributions to non-controlling interests	—			—			—			—		—			—			(510		)	(510		)
	Purchase of noncontrolling interest in consolidated partnership	—			(6,577		)	—			—		—			(6,577		)	(1,612		)	(8,189		)
	Balance at September 30, 2014	$	981		$	2,374,345		$	51		$	822,176	$	(1,978,046	)	$	1,219,507		$	—		$	1,219,507
Change in ownership interest in less-than-wholly-owned subsidiary	'
	The following schedule discloses the effects of changes in the Company's ownership interest in its less-than-wholly-owned subsidiary on the Company's stockholders' equity (in thousands):
		Nine Months Ended September 30, 2014
	Net income attributable to common stockholders	$	13,814
	Transfers to noncontrolling interest:
	Net decrease in the Company's additional paid-in capital for purchase of subsidiary partnership interest	(6,577		)
	Net transfers to the noncontrolling interest	(6,577		)
	Change to the Company's total stockholders' equity from net income attributable to common stockholders and transfers to noncontrolling interest	$	7,237
Reconciliation of beginning and ending common stock outstanding	'
	Common Stock
	The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September 30, 2014 and the year ended December 31, 2013:
		September 30, 2014			December 31, 2013
	Balance, beginning of period	95,924,339			87,514,336
	Issuance of common stock	2,149,976			8,293,369
	Nonvested share-based awards, net	44,231			116,634
	Balance, end of period	98,118,546			95,924,339
Earnings (loss) per share	'
	Earnings (Loss) Per Common Share
	The following table sets forth the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2014 and 2013.
		Three Months Ended September 30,								Nine Months Ended September 30,
	(Dollars in thousands, except per share data)	2014				2013				2014			2013
	Weighted average Common Shares outstanding
	Weighted average Common Shares outstanding	97,651,673				95,220,031				96,677,774			91,665,703
	Nonvested shares	(1,793,639		)		(1,777,203		)		(1,832,242		)	(1,794,606		)
	Weighted average Common Shares outstanding—Basic	95,858,034				93,442,828				94,845,532			89,871,097
	Weighted average Common Shares—Basic	95,858,034				93,442,828				94,845,532			89,871,097
	Dilutive effect of restricted stock	1,369,047				1,278,902				1,346,032			—
	Dilutive effect of employee stock purchase plan	101,963				114,264				118,854			—
	Weighted average Common Shares outstanding—Diluted	97,329,044				94,835,994				96,310,418			89,871,097
	Net Income (Loss)
	Income (loss) from continuing operations	$	8,537			$	4,614			$	25,233		$	(22,372	)
	Noncontrolling interests’ share in net (income) loss	(162		)		(18		)		(313		)	34
	Income (loss) from continuing operations attributable to common stockholders	8,375				4,596				24,920			(22,338		)
	Discontinued operations	(4,384		)		15,169				(11,106		)	16,899
	Net income (loss) attributable to common stockholders	$	3,991			$	19,765			$	13,814		$	(5,439	)
	Basic Earnings (Loss) Per Common Share
	Income (loss) from continuing operations	$	0.09			$	0.05			$	0.27		$	(0.25	)
	Discontinued operations	(0.05		)		0.16				(0.12		)	0.19
	Net income (loss) attributable to common stockholders	$	0.04			$	0.21			$	0.15		$	(0.06	)
	Diluted Earnings (Loss) Per Common Share
	Income (loss) from continuing operations	$	0.09			$	0.05			$	0.26		$	(0.25	)
	Discontinued operations	(0.05		)		0.16				(0.12		)	0.19
	Net income (loss) attributable to common stockholders	$	0.04			$	0.21			$	0.14		$	(0.06	)
Summary of the activity under the Incentive Plan	'
	A summary of the activity under the stock-based incentive plans for the three and nine months ended September 30, 2014 and 2013 is included in the table below.
		Three Months Ended September 30,						Nine Months Ended September 30,
		2014			2013			2014			2013
	Stock-based awards, beginning of period	1,837,855			1,778,083			1,788,168			1,770,061
	Granted	—			—			128,199			87,043
	Vested	(4,911	)		(890	)		(83,423	)		(79,911	)
	Forfeited	(67,798	)		—			(67,798	)		—
	Stock-based awards, end of period	1,765,146			1,777,193			1,765,146			1,777,193
Summary of employee stock purchase plan activity	'
	A summary of the activity under the Employee Stock Purchase Plan for the three and nine months ended September 30, 2014 and 2013 is included in the table below.
		Three Months Ended September 30,						Nine Months Ended September 30,
		2014			2013			2014			2013
	Outstanding and exercisable, beginning of period	440,471			433,801			391,108			433,452
	Granted	—			—			275,655			246,717
	Exercised	(11,668	)		(7,478	)		(40,988	)		(60,483	)
	Forfeited	(5,219	)		(14,007	)		(44,316	)		(36,819	)
	Expired	—			—			(157,875	)		(170,551	)
	Outstanding and exercisable, end of period	423,584			412,316			423,584			412,316

Defined_Benefit_Pension_Plan_T

Defined Benefit Pension Plan (Tables)	9 Months Ended
	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
Net periodic benefit cost recorded related to the Company's pension plans	'
	Net periodic benefit cost recorded related to the Company’s pension plan for the three and nine months ended September 30, 2014 and 2013 is detailed in the following table.
		Three Months Ended September 30,						Nine Months Ended September 30,
	(Dollars in thousands)	2014			2013			2014			2013
	Service cost	$	22		$	22		$	66		$	64
	Interest cost	172			149			515			448
	Amortization of net gain/loss	117			344			352			1,035
	Amortization of prior service cost	(297		)	(297		)	(892		)	(892		)
	Total recognized in net periodic benefit cost	$	14		$	218		$	41		$	655

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair value and carrying values for notes and bonds payable, mortgage notes receivable, and notes receivable	'
	The table below details the fair value and carrying values for notes and bonds payable and mortgage notes receivable at September 30, 2014 and December 31, 2013.
		September 30, 2014				December 31, 2013
	(Dollars in millions)	Carrying Value		Fair Value		Carrying Value		Fair Value
	Notes and bonds payable (1)	$	1,403.40	$	1,426.50	$	1,348.50	$	1,380.60
	Mortgage notes receivable (2)	$	1.9	$	1.9	$	125.5	$	124.5
	______
	(1) Level 3 - Fair value derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	(2) Level 2 - Fair value based on quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
Business Overview:	'	'
Gross investment amount, total	$3,200,000,000	$3,200,000,000
Number of real estate properties	201	201
Total number of company owned real estate properties	200	200
Number of states that the Company owns real estate in, whole units	30	30
Square footage of owned real estate properties	14,300,000	14,300,000
Approximate square feet for which Nationwide property management services provided by company	9,700,000	9,700,000
Interest and Other Income, Net [Member]	'	'
Interest and Other Income, Net [Abstract]	'	'
Reimbursement of prior period operating expenses	1,900,000	1,900,000
Gain on insurance proceeds	'	$300,000

Real_Estate_Investments_Assets

Real Estate Investments - Assets acquired and liabilities assumed (Details) (IOWA, USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Mar. 31, 2014
Acquisitions and Dispositions [Line Items]	'	'
Building	'	$38.10
Total intangibles	'	1.6
Foreclosed mortgage note receivable	'	-40
Other assets acquired	'	1.8
Accounts payable, accrued liabilities and other liabilities assumed	'	-1.7
Cash acquired	'	0.2
Total cash paid	'	0
At-market lease intangibles [Member]	'	'
Acquisitions and Dispositions [Line Items]	'	'
Total intangibles	'	2.1
Finite-Lived Intangible Asset, Useful Life	'5 years 9 months 18 days	'
Below Market Ground Lease Intangibles [Member]	'	'
Acquisitions and Dispositions [Line Items]	'	'
Total intangibles	'	-0.1
Finite-Lived Intangible Asset, Useful Life	'91 years 3 months 18 days	'
Below-market lease intangibles	'	'
Acquisitions and Dispositions [Line Items]	'	'
Total intangibles	'	($0.40)
Maximum [Member] | Below-market lease intangibles	'	'
Acquisitions and Dispositions [Line Items]	'	'
Finite-Lived Intangible Asset, Useful Life	'6 years 6 months	'
Minimum [Member] | Below-market lease intangibles	'	'
Acquisitions and Dispositions [Line Items]	'	'
Finite-Lived Intangible Asset, Useful Life	'3 years 9 months 18 days	'
Building [Member] | Maximum [Member]	'	'
Acquisitions and Dispositions [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'33 years	'
Building [Member] | Minimum [Member]	'	'
Acquisitions and Dispositions [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'11 years 6 months	'

Real_Estate_Investments_Discon

Real Estate Investments - Discontinued Operations and Assets Held for Sale - Balance Sheet (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Balance Sheet data (as of the period ended):	'	'
Land	$183,991	$178,931
Buildings, improvements and lease intangibles	3,030,960	2,861,935
Personal property	9,535	9,267
Real estate properties, Total	3,241,540	3,067,187
Less accumulated depreciation	-693,517	-632,109
Total real estate properties, net	2,548,023	2,435,078
Other assets, net (including receivables)	178,238	153,514
Assets held for sale and discontinued operations, net	11,479	6,852
Accounts payable and accrued liabilities	60,017	73,741
Other liabilities	57,913	61,064
Liabilities of discontinued operations	508	1,112
Discontinued Operations [Member]	'	'
Balance Sheet data (as of the period ended):	'	'
Land	1,674	1,578
Buildings, improvements and lease intangibles	22,232	15,400
Personal property	14	0
Real estate properties, Total	23,920	16,978
Less accumulated depreciation	-12,901	-10,211
Total real estate properties, net	11,019	6,767
Other assets, net (including receivables)	460	85
Assets of discontinued operations, net	460	85
Assets held for sale and discontinued operations, net	11,479	6,852
Accounts payable and accrued liabilities	482	1,091
Other liabilities	26	21
Liabilities of discontinued operations	$508	$1,112

Real_Estate_Investments_Discon1

Real Estate Investments - Discontinued Operations and Assets Held for Sale - Income Statement (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues	'	'	'	'
Rental income	$92,987	$78,161	$270,513	$230,094
Other Operating Income	1,475	1,579	4,349	4,542
Revenues	94,506	83,666	278,496	244,926
Expenses	'	'	'	'
Property operating	34,678	32,244	102,077	92,742
General and administrative	5,190	5,582	16,834	17,961
Depreciation	25,660	21,716	74,408	63,970
Amortization	2,656	2,595	8,190	7,819
Bad debt, net of recoveries	3	109	123	116
Total Expenses	68,187	62,246	201,632	182,608
Other Income (Expense)	'	'	'	'
Loss on extinguishment of debt	0	0	'	-29,638
Interest expense	-18,192	-17,043	-54,176	-55,738
Interest and other income, net	410	237	2,545	686
Total other income (expense)	-17,782	-16,806	-51,631	-84,690
Discontinued Operations	'	'	'	'
Income (loss) from discontinued operations	121	1,241	-75	4,818
Impairments	-4,505	-6,259	-11,034	-9,889
Gain on sales of real estate properties	0	20,187	3	21,970
INCOME (LOSS) FROM DISCONTINUED OPERATIONS	-4,384	15,169	-11,106	16,899
Discontinued Operations [Member]	'	'	'	'
Revenues	'	'	'	'
Rental income	465	2,608	1,689	9,771
Other Operating Income	0	0	0	1
Revenues	465	2,608	1,689	9,772
Expenses	'	'	'	'
Property operating	251	724	1,223	2,221
General and administrative	1	1	3	4
Depreciation	104	649	544	2,390
Amortization	0	12	0	55
Bad debt, net of recoveries	-4	3	3	3
Total Expenses	352	1,389	1,773	4,673
Other Income (Expense)	'	'	'	'
Loss on extinguishment of debt	0	0	0	-270
Interest expense	0	0	0	-40
Interest and other income, net	8	22	9	29
Total other income (expense)	8	22	9	-281
Discontinued Operations	'	'	'	'
Income (loss) from discontinued operations	121	1,241	-75	4,818
Impairments	-4,505	-6,259	-11,034	-9,889
Gain on sales of real estate properties	0	20,187	3	21,970
INCOME (LOSS) FROM DISCONTINUED OPERATIONS	($4,384)	$15,169	($11,106)	$16,899

Real_Estate_Investments_Narrat

Real Estate Investments - Narrative (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Apr. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Mar. 28, 2014

Mar. 31, 2014

Mar. 28, 2014

Sep. 30, 2014

Apr. 23, 2014

Mar. 31, 2014

Apr. 11, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 12, 2014

Sep. 30, 2014

Sep. 12, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

22-May-14

Sep. 30, 2014

22-May-14

Jun. 06, 2014

Jun. 06, 2014

Jun. 04, 2014

Jun. 04, 2014

Sep. 16, 2014

Sep. 16, 2014

Mar. 28, 2014

Mar. 28, 2014

Jul. 28, 2014

Jul. 31, 2014

Jul. 28, 2014

Jun. 04, 2014

Jun. 04, 2014

Jun. 04, 2014

Oct. 31, 2014

Mar. 31, 2015

sqft

sqft

Property

property

Discontinued Operations [Member]

Discontinued Operations [Member]

Discontinued Operations [Member]

Discontinued Operations [Member]

Discontinued Operations [Member]

TEXAS

TEXAS

PENNSYLVANIA

Other Mortgage Loans [Member]

Other Mortgage Loans [Member]

Other Mortgage Loans [Member]

Real Estate Dispositions [Member]

Real Estate Dispositions [Member]

Real Estate Dispositions [Member]

Real Estate Dispositions [Member]

Real Estate Dispositions [Member]

Real Estate Dispositions [Member]

Real Estate Dispositions [Member]

Real Estate Dispositions [Member]

Real Estate Dispositions [Member]

Mortgage Note Repayments [Member]

Transferred to Held For Sale [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Real Estate Acquisitions [Member]

Medical Office Building [Member]

Real Estate Assets [Member]

Real Estate Assets [Member]

Subsequent Event [Member]

Scenario, Forecast [Member]

property

property

Potential Disposition [Member]

Other Property [Member]

Other Property [Member]

Other Property [Member]

sqft

TEXAS

TEXAS

FLORIDA

FLORIDA

FLORIDA

NEVADA

NEVADA

NEVADA

mortgage_note_receivable

Discontinued Operations [Member]

sqft

OKLAHOMA

OKLAHOMA

OKLAHOMA

NORTH CAROLINA

NORTH CAROLINA

TEXAS

TEXAS

FLORIDA

FLORIDA

IOWA

IOWA

MINNESOTA

MINNESOTA

MINNESOTA

TEXAS

Medical Office Building [Member]

Medical Office Building [Member]

Real Estate Acquisitions [Member]

PENNSYLVANIA

IOWA

IOWA

IOWA

Medical Building Disposed April 23 2014 [Member]

Medical Building Disposed April 23 2014 [Member]

Medical Building Disposed April 11 2014 [Member]

Medical Building Disposed April 11 2014 [Member]

Medical Building Disposed April 11 2014 [Member]

Medical Building Disposed September 12, 2014 [Member]

Medical Building Disposed September 12, 2014 [Member]

Medical Building Disposed September 12, 2014 [Member]

sqft

sqft

sqft

sqft

sqft

sqft

TEXAS

TEXAS

OKLAHOMA

Potential Disposition [Member]

sqft

sqft

sqft

sqft

Acquisitions and Dispositions [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Square footage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

544,433

'

'

200,000

'

35,292

'

48,048

'

47,962

'

152,655

'

'

60,476

'

'

'

68,860

'

Purchase price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$128,300,000

$85,400,000

'

'

$6,500,000

'

$8,700,000

'

$7,900,000

'

$0

'

$19,800,000

[1]

'

'

'

'

'

$17,400,000

'

Cash consideration

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

35,800,000

4,200,000

'

'

6,500,000

'

8,800,000

'

7,900,000

'

'

'

8,400,000

[1]

'

'

'

'

'

10,600,000

'

Debt assumed

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

11,400,000

'

'

'

6,800,000

'

Mortgage contractual interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.10%

'

Fair value adjustment premium

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,200,000

1,200,000

'

'

'

'

'

'

Weighted average contractual interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.67%

'

'

'

'

'

Percentage of medical office building leased

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

'

100.00%

'

'

'

89.00%

'

'

'

'

100.00%

'

'

'

96.70%

'

Face amount of mortgages

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

81,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Additional funded amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Anticipated amount of investment

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Real estate properties, cost

3,241,540,000

'

3,241,540,000

'

'

3,067,187,000

23,920,000

'

23,920,000

'

16,978,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

91,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Limited liability company, ownership percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

56.90%

'

'

'

'

Cash consideration

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,800,000

'

'

Closing costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

Stated interest rate, percent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.70%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Incremental Interest Rate for Default

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exit fee

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Area Covered Under Real Estate Investment Sold in Measurement Units

141,999

'

141,999

'

'

'

'

'

'

'

'

'

'

'

'

'

'

141,999

58,365

[2]

'

52,608

[2]

'

'

'

'

31,026

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Real estate investment disposed of during period

10,700,000

'

10,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,700,000

4,100,000

[2]

'

1,700,000

[2]

'

'

'

'

4,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net investment in potential disposition

2,548,023,000

'

2,548,023,000

'

'

2,435,078,000

11,019,000

'

11,019,000

'

6,767,000

'

'

7,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Disposition Sales Price

8,500,000

'

8,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,500,000

4,400,000

[2]

'

1,800,000

[2]

'

'

'

'

2,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,000,000

Gain/(Impairment)

'

'

-2,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-2,800,000

'

'

'

'

'

-2,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7,300,000

Net cash proceeds

'

'

11,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,100,000

4,200,000

[2]

'

1,700,000

[2]

'

'

200,000

'

'

4,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Seller Financed Mortgage Notes Receivable

-3,000,000

'

-3,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,900,000

'

'

'

'

'

'

1,900,000

1,900,000

-4,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Closing costs on disposition

500,000

'

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

500,000

200,000

[2]

'

100,000

[2]

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Impairment charges

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,600,000

'

900,000

2,400,000

2,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Mortgage Notes Receivables Repaid

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Noncontrolling interest, ownership percentage by parent

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase of noncontrolling interests

'

'

'

'

'

'

'

'

'

'

'

8,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Noncontrolling interest

0

'

0

'

'

1,809,000

'

'

'

'

'

'

1,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Impairments

$4,505,000

$6,259,000

$11,034,000

$9,889,000

'

'

$4,505,000

$6,259,000

$11,034,000

$9,889,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of properties held for sale

4

'

4

'

3

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

The mortgage note payable assumed in the acquisition does not reflect the fair value adjustment of $1.2 million recorded by the Company upon acquisition (included in Other).

[2]

Previously included in assets held for sale.

Real_Estate_Investments_Acquis

Real Estate Investments - Acquisitions (Details) (Real Estate Acquisitions [Member], USD $)

9 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

In Millions, unless otherwise specified

Sep. 30, 2014

Mar. 28, 2014

Mar. 28, 2014

22-May-14

22-May-14

Jun. 04, 2014

Jun. 04, 2014

Jun. 06, 2014

Jun. 06, 2014

Jul. 28, 2014

Jul. 31, 2014

Jul. 28, 2014

Sep. 16, 2014

Sep. 16, 2014

sqft

IOWA

IOWA

OKLAHOMA

OKLAHOMA

TEXAS

TEXAS

NORTH CAROLINA

NORTH CAROLINA

MINNESOTA

MINNESOTA

MINNESOTA

FLORIDA

FLORIDA

sqft

sqft

sqft

sqft

sqft

sqft

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase Price

$128.30

$0

'

$85.40

'

$8.70

'

$6.50

'

$19.80

[1]

'

'

$7.90

'

Elimination of Mortgage Note Receivable

-121.2

-40

'

-81.2

'

'

'

'

'

'

'

'

'

'

Mortgage Notes Payable Assumed

-11.4

'

'

'

'

'

'

'

'

-11.4

[1]

'

'

'

'

Cash Consideration

35.8

'

'

4.2

'

8.8

'

6.5

'

8.4

[1]

'

'

7.9

'

Real Estate

169.8

'

40.2

'

85.4

'

8.8

'

6.5

'

'

21

[1]

'

7.9

Other

-1.4

'

-0.2

'

'

'

'

'

'

'

'

-1.2

[1]

'

'

Square Footage

544,433

'

152,655

'

200,000

'

48,048

'

35,292

'

'

60,476

'

47,962

Fair value adjustment premium

'

'

'

'

'

'

'

'

'

$1.20

$1.20

'

'

'

[1]

The mortgage note payable assumed in the acquisition does not reflect the fair value adjustment of $1.2 million recorded by the Company upon acquisition (included in Other).

Real_Estate_Investments_Dispos

Real Estate Investments - Dispositions (Details) (USD $)	9 Months Ended		0 Months Ended							9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Apr. 11, 2014		Apr. 23, 2014		Sep. 12, 2014	Sep. 30, 2014	Sep. 12, 2014	Sep. 30, 2014
	sqft	Real Estate Dispositions [Member]	Real Estate Dispositions [Member]		Real Estate Dispositions [Member]		Real Estate Dispositions [Member]	Real Estate Dispositions [Member]	Real Estate Dispositions [Member]	Mortgage Note Repayments [Member]
		sqft	Medical Building Disposed April 11 2014 [Member]		Medical Building Disposed April 23 2014 [Member]		Medical Building Disposed September 12, 2014 [Member]	Medical Building Disposed September 12, 2014 [Member]	Medical Building Disposed September 12, 2014 [Member]
			FLORIDA		TEXAS		NEVADA	NEVADA	NEVADA
			sqft		sqft				sqft
Acquisitions and Dispositions [Line Items]	'	'	'		'		'	'	'	'
Sales Price	$8.50	$8.50	$1.80	[1]	$4.40	[1]	'	'	$2.30	'
Closing Adjustments	-0.5	-0.5	-0.1	[1]	-0.2	[1]	'	'	-0.2	'
Company-financed Mortgage Notes	3	-1.9	'		'		'	-1.9	-1.9	4.9
Net Proceeds	11	6.1	1.7	[1]	4.2	[1]	0.2	'	'	4.9
Net Real Estate Investment	10.7	10.7	1.7	[1]	4.1	[1]	'	'	4.9	'
Other (including receivables)	0.1	0.1	'		0.1	[1]	'	'	'	'
Gain/(Impairment)	($2.80)	($2.80)	'		'		($2.80)	'	'	'
Square Footage	141,999	141,999	52,608	[1]	58,365	[1]	'	'	31,026	'
[1]	Previously included in assets held for sale.

Notes_and_Bonds_Payable_Detail

Notes and Bonds Payable (Details) (USD $)

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Jul. 31, 2014

Sep. 30, 2014

Feb. 28, 2014

Feb. 28, 2014

Feb. 28, 2014

Oct. 31, 2014

Oct. 31, 2014

Mortgage Bonds [Member]

Mortgage Bonds [Member]

Mortgage Bonds [Member]

Mortgage Bonds [Member]

Mortgage Bonds [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Medical Office Building [Member]

Medical Office Building [Member]

Series 2010A Bond due 2017 [Member]

Series 2010A Bond due 2022 [Member]

Series 2010A Bond due 2030 [Member]

Series 2010A Bond due 2040 [Member]

Term Loan Due 2019 [Member]

Term Loan Due 2019 [Member]

Term Loan Due 2019 [Member]

Term Loan Due 2019 [Member]

VIRGINIA

VIRGINIA

Lender

Minimum [Member]

Maximum [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Mortgage

Mortgages [Member]

building

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt assumed

'

'

$11,400,000

$500,000

$1,200,000

$2,800,000

$7,000,000

'

'

'

'

'

'

Fair value adjustment premium

'

'

1,200,000

'

'

'

'

'

'

'

'

'

'

Weighted average contractual interest rate

'

'

6.67%

'

'

'

'

'

'

'

'

'

6.08%

Effective interest rate

'

'

4.79%

'

'

'

'

'

'

'

'

'

4.06%

Debt face amount

'

'

'

'

'

'

'

'

200,000,000

'

'

'

'

Number of term loan lenders

'

'

'

'

'

'

'

'

9

'

'

'

'

Basis spread on variable rate

'

'

'

'

'

'

'

1.45%

'

1.00%

1.95%

'

'

Number of mortgages repaid

'

'

'

'

'

'

'

'

'

'

'

3

'

Repayments of mortgages

$4,415,000

$18,655,000

'

'

'

'

'

'

'

'

'

'

$6,300,000

Number of medical office buildings

'

'

'

'

'

'

'

'

'

'

'

'

2

Equity_Reconciliation_of_total

Equity - Reconciliation of total stockholders' equity (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Increase (Decrease) in Stockholders' Equity [Rollforward]	'	'	'	'
Balance at December 31, 2013	'	'	$1,245,286	'
Issuance of common stock	'	'	52,698	'
Common stock redemptions	'	'	-382	'
Stock-based compensation	'	'	3,400	'
Net income	4,153	19,783	14,127	-5,473
Dividends to common stockholders ($0.60 per share)	'	'	-86,923	'
Distributions to non-controlling interests	'	'	-510	'
Purchase of noncontrolling interest in consolidated partnership	'	'	-8,189	'
Balance at September 30, 2014	1,219,507	'	1,219,507	'
Common Stock [Member]	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Rollforward]	'	'	'	'
Balance at December 31, 2013	'	'	959	'
Issuance of common stock	'	'	21	'
Common stock redemptions	'	'	'	'
Stock-based compensation	'	'	1	'
Net income	'	'	'	'
Dividends to common stockholders ($0.60 per share)	'	'	'	'
Distributions to non-controlling interests	'	'	'	'
Purchase of noncontrolling interest in consolidated partnership	'	'	'	'
Balance at September 30, 2014	981	'	981	'
Additional Paid-In Capital [Member]	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Rollforward]	'	'	'	'
Balance at December 31, 2013	'	'	2,325,228	'
Issuance of common stock	'	'	52,677	'
Common stock redemptions	'	'	-382	'
Stock-based compensation	'	'	3,399	'
Net income	'	'	'	'
Dividends to common stockholders ($0.60 per share)	'	'	'	'
Distributions to non-controlling interests	'	'	'	'
Purchase of noncontrolling interest in consolidated partnership	'	'	-6,577	'
Adjustments to Additional Paid in Capital, Redemptions or Purchase of Interests	'	'	6,577	'
Balance at September 30, 2014	2,374,345	'	2,374,345	'
Accumulated Other Comprehensive Loss [Member]	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Rollforward]	'	'	'	'
Balance at December 31, 2013	'	'	51	'
Issuance of common stock	'	'	'	'
Common stock redemptions	'	'	'	'
Stock-based compensation	'	'	'	'
Net income	'	'	'	'
Dividends to common stockholders ($0.60 per share)	'	'	'	'
Distributions to non-controlling interests	'	'	'	'
Purchase of noncontrolling interest in consolidated partnership	'	'	'	'
Balance at September 30, 2014	51	'	51	'
Cumulative Net Income Attributable to Common Stockholders [Member]	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Rollforward]	'	'	'	'
Balance at December 31, 2013	'	'	808,362	'
Issuance of common stock	'	'	'	'
Common stock redemptions	'	'	'	'
Stock-based compensation	'	'	'	'
Net income	'	'	13,814	'
Dividends to common stockholders ($0.60 per share)	'	'	'	'
Distributions to non-controlling interests	'	'	'	'
Purchase of noncontrolling interest in consolidated partnership	'	'	'	'
Balance at September 30, 2014	822,176	'	822,176	'
Cumulative Dividends [Member]	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Rollforward]	'	'	'	'
Balance at December 31, 2013	'	'	-1,891,123	'
Issuance of common stock	'	'	'	'
Common stock redemptions	'	'	'	'
Stock-based compensation	'	'	'	'
Net income	'	'	'	'
Dividends to common stockholders ($0.60 per share)	'	'	-86,923	'
Distributions to non-controlling interests	'	'	'	'
Purchase of noncontrolling interest in consolidated partnership	'	'	'	'
Balance at September 30, 2014	-1,978,046	'	-1,978,046	'
Total Stockholders' Equity [Member]	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Rollforward]	'	'	'	'
Balance at December 31, 2013	'	'	1,243,477	'
Issuance of common stock	'	'	52,698	'
Common stock redemptions	'	'	-382	'
Stock-based compensation	'	'	3,400	'
Net income	'	'	13,814	'
Dividends to common stockholders ($0.60 per share)	'	'	-86,923	'
Distributions to non-controlling interests	'	'	'	'
Balance at September 30, 2014	1,219,507	'	1,219,507	'
Noncontrolling Interest [Member]	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Rollforward]	'	'	'	'
Balance at December 31, 2013	'	'	1,809	'
Issuance of common stock	'	'	'	'
Common stock redemptions	'	'	'	'
Stock-based compensation	'	'	'	'
Net income	'	'	313	'
Dividends to common stockholders ($0.60 per share)	'	'	'	'
Distributions to non-controlling interests	'	'	-510	'
Purchase of noncontrolling interest in consolidated partnership	'	'	-1,612	'
Balance at September 30, 2014	'	'	'	'

Equity_Change_in_ownership_of_

Equity - Change in ownership of less-than-wholly-owned subsidiary (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Noncontrolling Interest [Line Items]	'	'	'	'
Net income	$4,153	$19,783	$14,127	($5,473)
Net transfers to the noncontrolling interest	'	'	-8,189	'
Change to the Company's total stockholders' equity from net income attributable to common stockholders and transfers to noncontrolling interest	'	'	7,237	'
Cumulative Net Income Attributable to Common Stockholders [Member]	'	'	'	'
Noncontrolling Interest [Line Items]	'	'	'	'
Net income	'	'	13,814	'
Net transfers to the noncontrolling interest	'	'	'	'
Additional Paid-in Capital [Member]	'	'	'	'
Noncontrolling Interest [Line Items]	'	'	'	'
Net income	'	'	'	'
Net decrease in the Company's additional paid-in capital for purchase of subsidiary partnership interest	'	'	-6,577	'
Net transfers to the noncontrolling interest	'	'	($6,577)	'

Equity_Reconciliation_of_begin

Equity - Reconciliation of beginning and ending common stock outstanding (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Reconciliation of the beginning and ending common stock outstanding	'	'
Balance, end of period	98,119,000	95,924,000
Common Stock [Member]	'	'
Reconciliation of the beginning and ending common stock outstanding	'	'
Balance, beginning of period	95,924,339	87,514,336
Issuance of common stock	2,149,976	8,293,369
Nonvested share-based awards, net	44,231	116,634
Balance, end of period	98,118,546	95,924,339

Equity_Computation_of_basic_an

Equity - Computation of basic and diluted earnings (loss) per common share (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Weighted average Common Shares outstanding	'	'	'	'
Weighted average Common Shares outstanding	97,651,673	95,220,031	96,677,774	91,665,703
Nonvested shares	-1,793,639	-1,777,203	-1,832,242	-1,794,606
Weighted average Common Shares—Basic	95,858,034	93,442,828	94,845,532	89,871,097
Dilutive effect of restricted stock	1,369,047	1,278,902	1,346,032	'
Dilutive effect of employee stock purchase plan	101,963	114,264	118,854	'
Weighted average Common Shares outstanding—Diluted	97,329,044	94,835,994	96,310,418	89,871,097
Net Income (Loss)	'	'	'	'
Income from continuing operations	$8,537	$4,614	$25,233	($22,372)
Noncontrolling interests’ share in net (income) loss	-162	-18	-313	34
Income (loss) from continuing operations attributable to common stockholders	8,375	4,596	24,920	-22,338
Discontinued operations	-4,384	15,169	-11,106	16,899
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	$3,991	$19,765	$13,814	($5,439)
Basic Earnings (Loss) Per Common Share	'	'	'	'
Income (loss) from continuing operations (in dollars per share)	$0.09	$0.05	$0.27	($0.25)
Discontinued operations (in dollars per share)	($0.05)	$0.16	($0.12)	$0.19
Net income (loss) attributable to common stockholders (in dollars per share)	$0.04	$0.21	$0.15	($0.06)
Diluted Earnings (Loss) Per Common Share	'	'	'	'
Income (loss) from continuing operations (in dollars per share)	$0.09	$0.05	$0.26	($0.25)
Discontinued operations (in dollars per share)	($0.05)	$0.16	($0.12)	$0.19
Net income (loss) attributable to common stockholders (in dollars per share)	$0.04	$0.21	$0.14	($0.06)
Restricted Stock [Member]	'	'	'	'
Diluted Earnings (Loss) Per Common Share	'	'	'	'
Antidilutive securities excluded from computation of earnings per share, amount	'	'	'	1,294,953
Employee Stock [Member]	'	'	'	'
Diluted Earnings (Loss) Per Common Share	'	'	'	'
Antidilutive securities excluded from computation of earnings per share, amount	'	'	'	164,418

Equity_Summary_of_activity_und

Equity - Summary of activity under stock-based incentive plans (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Restricted Stock All [Member]	'	'	'	'
Summary of the activity under the incentive plans	'	'	'	'
Stock-based awards, beginning of period (shares)	1,837,855	1,778,083	1,788,168	1,770,061
Granted (shares)	0	0	128,199	87,043
Vested (shares)	-4,911	-890	-83,423	-79,911
Forfeited (shares)	-67,798	0	-67,798	0
Stock-based awards, end of period (shares)	1,765,146	1,777,193	1,765,146	1,777,193
Stock Incentive Plan [Member] | Restricted Stock [Member]	'	'	'	'
Summary of the activity under the incentive plans	'	'	'	'
Shares withheld to pay estimated withholding taxes	'	'	16,170	9,433

Equity_Summary_of_activity_und1

Equity - Summary of activity under Employee Stock Purchase Plan (Details) (Employee Stock Purchase Plan [Member], USD $)	3 Months Ended		9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Summary of the Employee Stock Purchase Plan activity	'	'	'	'
Outstanding and exercisable, beginning of period (shares)	440,471	433,801	391,108	433,452
Granted (shares)	0	0	275,655	246,717
Exercised (shares)	-11,668	-7,478	-40,988	-60,483
Forfeited (shares)	-5,219	-14,007	-44,316	-36,819
Expired (shares)	0	0	-157,875	-170,551
Outstanding and exercisable, end of period (shares)	423,584	412,316	423,584	412,316
General and Administrative Expense	'	'	'	'
Summary of the Employee Stock Purchase Plan activity	'	'	'	'
Share-based compensation expense	'	'	0.2	'

Equity_Stock_Transactions_Narr

Equity (Stock Transactions - Narrative) (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

In Thousands, except Share data, unless otherwise specified

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Nov. 04, 2014

Oct. 31, 2014

Nov. 04, 2014

Sep. 30, 2014

Sep. 30, 2014

Oct. 31, 2014

Sep. 30, 2014

Sep. 30, 2014

Oct. 31, 2014

Sep. 30, 2014

Sep. 30, 2014

Oct. 31, 2014

At The Market Equity Offering Program [Member]

At The Market Equity Offering Program [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Weighted Average [Member]

Weighted Average [Member]

Weighted Average [Member]

investment_bank

investment_bank

At The Market Equity Offering Program [Member]

At The Market Equity Offering Program [Member]

At The Market Equity Offering Program [Member]

At The Market Equity Offering Program [Member]

Subsequent Event [Member]

At The Market Equity Offering Program [Member]

At The Market Equity Offering Program [Member]

Subsequent Event [Member]

At The Market Equity Offering Program [Member]

At The Market Equity Offering Program [Member]

Subsequent Event [Member]

At The Market Equity Offering Program [Member]

At The Market Equity Offering Program [Member]

At The Market Equity Offering Program [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock (shares)

'

'

'

'

999,080

2,099,380

'

58,504

'

'

'

'

'

'

'

'

'

'

Issuance of common stock (price per share)

'

'

'

'

'

'

'

'

'

$24.35

$24.35

$25

$25.50

$25.84

$25.35

$24.93

$25.05

$25.32

Net proceeds from issuance of common stock

'

'

$52,712

$220,045

$24,500

$51,800

'

$1,500

'

'

'

'

'

'

'

'

'

'

Number of investment banks in sales agreements

'

'

'

'

4

4

'

'

'

'

'

'

'

'

'

'

'

'

Shares authorized to be sold under the program

'

'

'

'

9,000,000

9,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Number of authorized shares remaining under offering program

'

'

'

'

'

'

'

'

3,233,516

'

'

'

'

'

'

'

'

'

Dividends per share paid to common stockholders (in dollars per share)

'

'

$0.90

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividends per share declared to common stockholders (in dollars per share)

$0.30

$0.30

$0.90

$0.90

'

'

$0.30

'

'

'

'

'

'

'

'

'

'

'

Defined_Benefit_Pension_Plan_D

Defined Benefit Pension Plan (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
			Officer
Compensation and Retirement Disclosure [Abstract]	'	'	'	'
Number of founding Officers Eligible for Retirement Benefit Plan	'	'	3	'
Maximum annual benefits payable under the Executive Retirement Plan, frozen subject to cost-of-living adjustments	$900,000	'	$900,000	'
Net periodic benefit cost recorded related to the Company's pension plans	'	'	'	'
Service costs	22,000	22,000	66,000	64,000
Interest costs	172,000	149,000	515,000	448,000
Amortization of net gain/loss	117,000	344,000	352,000	1,035,000
Amortization of prior service cost	-297,000	-297,000	-892,000	-892,000
Total recognized in net periodic benefit cost	$14,000	$218,000	$41,000	$655,000

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments (Details) (USD $)	Sep. 30, 2014		Dec. 31, 2013
Fair Value Disclosures [Abstract]	'		'
Notes and bonds payable, Carrying value	$1,403,379,000		$1,348,459,000
Mortgage notes receivable, Carrying value	1,900,000		125,547,000
Notes and bonds payable, Fair value	1,426,500,000	[1]	1,380,600,000	[1]
Mortgage notes receivable, Fair value	$1,900,000	[2]	$124,500,000	[2]
[1]	Level 3 - Fair value derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
[2]	Level 2 - Fair value based on quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets.